Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
about
Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis.Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease.Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.The protein family TcTASV-C is a novel Trypanosoma cruzi virulence factor secreted in extracellular vesicles by trypomastigotes and highly expressed in bloodstream forms.
P2860
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cysteine mutagenesis improves ...... date for human chagas disease.
@en
Cysteine mutagenesis improves ...... date for human chagas disease.
@nl
type
label
Cysteine mutagenesis improves ...... date for human chagas disease.
@en
Cysteine mutagenesis improves ...... date for human chagas disease.
@nl
prefLabel
Cysteine mutagenesis improves ...... date for human chagas disease.
@en
Cysteine mutagenesis improves ...... date for human chagas disease.
@nl
P2093
P2860
P50
P1476
Cysteine mutagenesis improves ...... date for human chagas disease.
@en
P2093
Brian Keegan
C Patrick McAtee
Christopher A Seid
Elissa Hudspeth
Jonathan L Respress
Junfei Wei
Kathryn M Jones
Leroy Versteeg
Molly Hammond
P2860
P304
P356
10.1080/21645515.2016.1242540
P577
2016-10-13T00:00:00Z